title: Study of GH sensitivity in chilean patients with idiopathic short stature.
abstract: We hypothesized that some children with idiopathic short stature in Chile might bear heterozygous mutations of the GH receptor. We selected 26 patients (3 females, 23 males) from 112 patients who consulted for idiopathic short stature at the University of Chile. Their chronological age was 8.3 +/- 1.9, and bone age was 6.1 +/- 1.0 yr. Their height was -3.0 +/- 0.7 SDS; IGF-I, -1.2 +/- 1.1 SD; IGF binding protein 3, -0.7 +/- 2.0 SDS; and GH binding protein, 0.4 +/- 0.8 SDS. Patients were admitted, and blood samples were obtained every 20 min to determine GH concentrations overnight. Coding sequences and intron-exon boundaries of exons 2-10 of GH receptor gene were amplified by PCR and subsequently analyzed through single-strand conformational analysis. Mean serum GH concentration, over 12-h, was 0.20 +/- 0.08 nM; pulse amplitude, 0.40 +/- 0.15 nM; number of peaks, 5.8 +/-1.5 peaks/12 h; peak value of GH during the 12-h sampling, 1.03 +/- 0.53 nM; and area under the curve, 151.4 +/- 56.1 nM/12 h. There were positive correlations between mean GH vs. area under the curve (P < 0.001) and GH peak (P < 0.01). The single-strand conformational analysis of the GH receptor gene showed abnormal migration for exon 6 in 9 patients and for exon 10 in 9 patients, which (by sequence analysis) corresponded to 2 polymorphisms of the GH receptor gene: an A-to-G transition in third position of codon 168 in exon 6 and a C-to-A transversion in the first position of codon 526 in exon 10. We further sequenced all coding exons and intron-exon boundaries in the most affected patients (nos. 6, 9, 11, 14, 15, 16, and 23). This analysis revealed a C-to-T transition in codon 161 of exon 6 in patient 23, which results in an amino acid change (Arg to Cys) in an heterozygous form in the patient and his father. In conclusion, the results of our study suggest that, in Chilean patients with idiopathic short stature, GH receptor gene mutations are uncommon, although we cannot exclude mutations that were missed by single-strand conformational analysis or mutations within introns or in the promoter regions of the GH receptor gene.
authors.affiliation: Institute of Maternal and Child Research (IDIMI), Faculty of Medicine, University of Chile, Santiago.
authors.forename: M
authors.initials: M
authors.lastname: Sjoberg
authors.forename: T
authors.initials: T
authors.lastname: Salazar
authors.forename: C
authors.initials: C
authors.lastname: Espinosa
authors.forename: A
authors.initials: A
authors.lastname: Dagnino
authors.forename: A
authors.initials: A
authors.lastname: Avila
authors.forename: M
authors.initials: M
authors.lastname: Eggers
authors.forename: F
authors.initials: F
authors.lastname: Cassorla
authors.forename: P
authors.initials: P
authors.lastname: Carvallo
authors.forename: M V
authors.initials: MV
authors.lastname: Mericq
mesh_terms: D001345:Autoradiography; D001483:Base Sequence; D001827:Body Height / Q000235:genetics*; D002648:Child; D002675:Child, Preschool; D002677:Chile; D017931:DNA Primers; D005091:Exons / Q000235:genetics; D005260:Female; D006130:Growth Disorders / Q000235:genetics*; D006579:Heterozygote; D006720:Homozygote; D019382:Human Growth Hormone / Q000235:genetics* / Q000502:physiology*; D006801:Humans; D008297:Male; D008967:Molecular Biology; D009154:Mutation / Q000235:genetics; D010375:Pedigree; D011863:Radioimmunoassay; D011986:Receptors, Somatotropin / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D017931:DNA Primers; D011986:Receptors, Somatotropin; D019382:Human Growth Hormone